NOF

NOF EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of NOF (4403.T) as of Nov 3, 2026 is 14.44. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 15.11 — a change of -4.44% (lower).

EV/EBIT

14.44

YoY

-4.44%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of NOF is 2026 14.44 . EV/EBIT (Enterprise Value to EBIT) of NOF was 2025 15.11 . It decreases by -4.44% lower compared to the previous year.

The NOF EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2019
24.08 JPY
Jan 1, 2020
25.48 JPY
Jan 1, 2021
25.74 JPY
Jan 1, 2022
19.24 JPY
Jan 1, 2023
16.86 JPY
Jan 1, 2024
16.25 JPY
Jan 1, 2025
15.11 JPY
Jan 1, 2026
14.44 JPY
The NOF EV/EBIT history
YEAREV/EBITYoY
14.44-4.44%
15.11-6.99%
16.25-3.60%
16.86-12.38%
19.24-25.26%
25.74+1.02%
25.48+5.84%
24.08-9.23%
26.52-5.73%
28.14-20.43%
35.36-11.76%
40.07-10.18%
44.62+301.24%
11.12+74.84%
6.36-9.27%
7.01-47.45%
13.34-35.18%
20.58+205.34%
6.74+15.61%
5.83—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NOF Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides NOF's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates NOF's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots NOF's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if NOF grows earnings faster than its peers.

NOF Stock analysis

What does NOF do? NOF Corporation is a Japanese company that has been operating in various industries since its establishment in 1911. It started as a manufacturer of chemicals, particularly olefinic derivatives, and soon discovered other sectors. Today, NOF Corp is a major player in the pharmaceutical, life sciences, and materials science industries. NOF Corp is headquartered in Tokyo and has branches and subsidiaries in various countries. It is listed on the Tokyo Stock Exchange and employs over 2,500 people worldwide. History: NOF Corp was founded in 1911 as a trading company specializing in the sale of chemicals. In the 1920s, the company began producing synthetic camphor, an important raw material in the fragrance and medical fields. During World War II, NOF manufactured military goods, including ammunition, aircraft components, and synthetic fibers. After the war, the company refocused on chemistry and expanded its presence in other countries, particularly in the United States and Europe. In the 1980s, NOF expanded into new industries such as advertising, marketing, and real estate. Currently, the company focuses on three main business areas: pharmaceuticals, life sciences, and materials science. Business Model: NOF Corp is a B2B company that primarily sells its products to other businesses. The company focuses on providing high-quality products tailored to the diverse needs of its customers. One of the company's principles is to constantly develop innovations to offer its customers a high level of quality and performance. NOF Corp also collaborates closely with companies and universities to advance research and development together. The company invests in research and development activities to offer innovative and effective solutions to its customers. Divisions: NOF Corp is divided into three main business segments: pharmaceuticals, life sciences, and materials science. Pharmaceuticals: NOF Corp produces a variety of pharmaceutical products, including active ingredients, intermediates, and excipients. These products are used by pharmaceutical companies worldwide to manufacture a wide range of drugs. Life Sciences: NOF Corp produces high-quality biochemicals and accessories to support cell growth in biotechnology and life sciences research. The company also manufactures polyethylene glycol-based products that are widely used in the pharmaceutical and life sciences industries. Materials Science: NOF Corp produces and supplies a range of materials, including electronic materials, polymers, separation membranes, and specialty resins. These materials are used in various industries such as electronics, automotive manufacturing, and energy supply. Products: NOF Corp offers a wide range of products, including: - Pharmaceutical active ingredients: NOF Corp manufactures active ingredients used in various medications. - Biochemicals: NOF Corp supplies chemical products used in cell culture in the life sciences industry. - Electronic materials: The company produces a range of high-tech materials used in the electronics industry. - Specialty resins: NOF Corp produces resins used in various areas such as the automotive industry and pipe manufacturing. - Separation membranes: NOF Corp offers membranes used in water treatment, wastewater treatment, and chemical separation. In summary, NOF Corp is a versatile company that manufactures a wide range of products in the pharmaceutical, life sciences, and materials science fields. The company has a long history and is committed to developing innovations to provide its customers with innovative solutions and high-quality products. NOF is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NOF stock

EV/EBIT (Enterprise Value to EBIT) of NOF is 14.44 in 2026.

EV/EBIT (Enterprise Value to EBIT) of NOF changed from 15.11 to 14.44, representing a -4.44% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) NOF since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s NOF with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — NOF

All Key Metrics — NOF